Hypertriglyceridaemia

总结

  • Incidence increasing along with number of patients who are overweight or obese.
  • Associated with increased cardiovascular risk.
  • May cause acute pancreatitis when fasting levels >5.7 mmol/L (500 mg/dL).
  • Treatment includes lifestyle modification for all patients.
  • Statins are generally first-line pharmacotherapy in patients with triglycerides <5.69 mmol/L (<500 mg/dL) in the presence of ≥2 cardiac risk factors.
  • Fibric acid derivatives, fish oils, and/or nicotinic acid may be added to statins, to achieve targets, in patients with triglycerides <5.69 mmol/L (<500 mg/dL), or as first-line therapy in those with triglycerides ≥5.69 mmol/L (≥500 mg/dL).
最后更新于: 四月 25, 2013
Top

Use of this content is subject to our disclaimer